About Us

Susanne has held senior positions as a biopharmaceutical commercial leader with a specialization in Global Market Access, Pricing, and Health Equity.  She has an established track record of developing and implementing commercialization strategies for pipeline and launch programs, including alignment with clinical trial strategy, evidence generation planning, development of launch pricing and reimbursement strategies, and strategies to negotiate with payers and HTA authorities. 

Her experience is based on 25 years in the industry including product launches in hyperlipidemia, osteoporosis, neurology, and rare-disease therapies into global markets.  Her previous roles included SVP and Head of Global Access, Pricing, and External Engagement at Belgian-based UCB S.A., and several leadership positions in Global Value, Access & Policy at Amgen, Inc. 

Susanne received a Chemistry BSc degree from Duke University, a Masters in Chemistry from the University of Virginia, and an MBA from the University of North Carolina at Chapel Hill.